Two types of genetic risk scores (GRS) have been devised to identify patients who will benefit most from cardiovascular-drug treatment: one related to the intermediate phenotype within a causal pathway, and another related to the expected clinical event. These GRS are promising and might have clinical implications for future practice.
- J. Wouter Jukema
- Stella Trompet
